CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 178 enrolled
Drug / intervention
Olmesartan medoxomil +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00412932
NCT00412932Phase 4Completed
CompareCT.gov

A Prospective, Open Label, Single Arm Study to Evaluation the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Elderly Patients With Hypertension

Daiichi Sankyo·interventional·Posted Dec 19, 2006·Updated Sep 22, 2009

In Brief

A Phase 4 clinical trial evaluating Olmesartan medoxomil and Olmesartan medoxomil/hydrochlorothiazide for Hypertension. Completed, enrolled 178 participants across 29 sites.

Detailed Summary

This 14 week study will examine the ability of olmesartan medoxomil to lower the blood pressure of patients 65 years of age or older with high blood pressure. The medication being tested has been approved by the FDA for the treatment of high blood pressure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 19, 2006
Enrollment StartDec 1, 2006
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 19.5 years ago

Interventions

Olmesartan medoxomildrug

Tablets

Olmesartan medoxomil/hydrochlorothiazidedrug

Tablets